Cancellation of state registration. Amoxicillin

March 02, 2017
Active substances:
Trade names:
ICD-10:
I.A20-A28.A27    Leptospirosis
I.A30-A49.A32    Listeriosis
I.A50-A64.A54    Gonococcal infection
X.J00-J06.J03    Acute tonsillitis
X.J10-J18.J15    Bacterial pneumonia, not elsewhere classified
X.J20-J22.J20    Acute bronchitis
X.J30-J39.J35.0    Chronic tonsillitis
X.J40-J47.J42    Chronic bronchitis, unspecified
XI.K20-K31.K25    Stomach ulcer
XI.K20-K31.K26    Duodenal ulcer
XI.K20-K31.K29    Gastritis and duodenitis
XII.L00-L08.L01    Impetigo
XII.L00-L08.L02    Abscess of skin, boil and carbuncle
XII.L00-L08.L03    Phlegmon
XII.L00-L08.L08.0    Pyoderma
XIV.N10-N16.N11    Chronic tubulointerstitial nephritis
XIV.N10-N16.N10    Acute tubulointerstitial nephritis
XIV.N30-N39.N30    Cystitis
XIV.N30-N39.N34    Urethritis and urethral syndrome
XIV.N70-N77.N70    Salpingitis and oophoritis
XIV.N70-N77.N71.0    Acute inflammatory disease of the uterus
XIV.N70-N77.N72    Inflammatory disease of the cervix
Amoxicillin, penicillin, bronchitis, tonsillitis, stomach ulcer, duodenal ulcer, pyelonephritis, gonorrhea, pneumonia, infectious and inflammatory skin diseases

The Ministry of Health of the Russian Federation, in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On the circulation of medicinal products", decided to abolish state registration and exclude from the state register of medicinal products for the medical use of the medicinal product (registration certificate No. N014454 / 02 from 13.10.2008 issued by Natur Product Europe BV, the Netherlands):

Amoxicillin (trade name of the medicinal product)

Amoxicillin (international non-proprietary or grouping or chemical name)

film coated tablets, 500 mg (dosage form, dosage)

Natur Product Europe BV, Netherlands Tweeber 17, 5246 XL Rosmalen, The Netherlands (name and address of the location of the manufacturer of the medicinal product)

on the basis of filing an application by the authorized legal entity LLC "VALEANT" to cancel the state registration of the medicinal product.